TY - JOUR
T1 - Accessory Genomes Drive Independent Spread of Carbapenem- Resistant Klebsiella pneumoniae Clonal Groups 258 and 307 in Houston, TX
AU - Shropshire, William C.
AU - Dinh, An Q.
AU - Earley, Michelle
AU - Komarow, Lauren
AU - Panesso, Diana
AU - Rydell, Kirsten
AU - Gómez-Villegas, Sara I.
AU - Miao, Hongyu
AU - Hill, Carol
AU - Chen, Liang
AU - Patel, Robin
AU - Fries, Bettina C.
AU - Abbo, Lilian
AU - Cober, Eric
AU - Revolinski, Sara
AU - Luterbach, Courtney L.
AU - Chambers, Henry
AU - Fowler, Vance G.
AU - Bonomo, Robert A.
AU - Shelburne, Samuel A.
AU - Kreiswirth, Barry N.
AU - van Duin, David
AU - Hanson, Blake M.
AU - Arias, Cesar A.
N1 - Funding Information:
C.A.A. reports grants from NIH, Merck, Memed Diagnostics, and Entasis pharmaceuticals; royalties from UpToDate; and an editor’s stipend from the American Society for Microbiology. V.G.F. reports personal consultancy fees from Novartis, Novadigm, Durata, Debiopharm, Genentech, Achaogen, Affinium, Medicines Co., Cerexa, Tetraphase, Trius, MedImmune, Bayer, Theravance, Basilea, Affinergy, Janssen, xBiotech, Contrafect, Regeneron, Basilea, Destiny, AmpliPhi Biosciences, Integrated Biotherapeutics, C3J, Armata, Valanbio, Akagera, and Aridis; grants from NIH, MedImmune, Allergan, Pfizer, Advanced Liquid Logics, Theravance, Novartis, Merck, Medical Biosurfaces, Locus, Affinergy; Contrafect, Karius, Genentech, Regeneron, Basilea, and Janssen; royalties from UpToDate; stock options from Valanbio; a patent pending in sepsis diagnostics; educational fees from Green Cross, Cubist, Cerexa, Durata, Theravance, and Debiopharm; and an editor’s stipend from IDSA.
Funding Information:
Support for this study was provided by the National Institute of Allergy and Infectious Diseases (NIAID) K24AI121296, R01AI134637, R01AI148342-01, R21AI143229, and P01AI152999-01, a UTHealth Presidential Award, University of Texas System STARS Award, and Texas Medical Center Health Policy Institute Funding Program to C.A.A. B.M.H. was supported by the NIAID K01AI148593-01. D.V.D. was supported by NIH/ NIAID grant R01AI143910. B.C.F. was funded using U.S. Veterans Affairs Merit Review Award 5I01 BX003741. BCF is an attending at the U.S. Department of Veterans Affairs - Northport VA Medical Center, Northport, NY. Additionally, part of this work was supported by NIAID of the National Institutes of Health under award no. UM1AI104681. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health or Department of Veterans Affairs.
Publisher Copyright:
© 2022 Shropshire et al.
PY - 2022/4
Y1 - 2022/4
N2 - Carbapenem-resistant Klebsiella pneumoniae (CRKp) is an urgent public health threat. Worldwide dissemination of CRKp has been largely attributed to clonal group (CG) 258. However, recent evidence indicates the global emergence of a CRKp CG307 lineage. Houston, TX, is the first large city in the United States with detected cocirculation of both CRKp CG307 and CG258. We sought to characterize the genomic and clinical factors contributing to the parallel endemic spread of CG258 and CG307. CRKp isolates were collected as part of the prospective, Consortium on Resistance against Carbapenems in Klebsiella and other Enterobacterales 2 (CRACKLE-2) study. Hybrid short-read and long-read genome assemblies were generated from 119 CRKp isolates (95 originated from Houston hospitals). A comprehensive characterization of phylogenies, gene transfer, and plasmid content with pan-genome analysis was performed on all CRKp isolates. Plasmid mating experiments were performed with CG307 and CG258 isolates of interest. Dissection of the accessory genomes suggested independent evolution and limited horizontal gene transfer between CG307 and CG258 lineages. CG307 contained a diverse repertoire of mobile genetic elements, which were shared with other non-CG258 K. pneumoniae isolates. Three unique clades of Houston CG307 isolates clustered distinctly from other global CG307 isolates, indicating potential selective adaptation of particular CG307 lineages to their respective geographical niches. CG307 strains were often isolated from the urine of hospitalized patients, likely serving as important reservoirs for genes encoding carbapenemases and extendedspectrum b-lactamases. Our findings suggest parallel cocirculation of high-risk lineages with potentially divergent evolution.
AB - Carbapenem-resistant Klebsiella pneumoniae (CRKp) is an urgent public health threat. Worldwide dissemination of CRKp has been largely attributed to clonal group (CG) 258. However, recent evidence indicates the global emergence of a CRKp CG307 lineage. Houston, TX, is the first large city in the United States with detected cocirculation of both CRKp CG307 and CG258. We sought to characterize the genomic and clinical factors contributing to the parallel endemic spread of CG258 and CG307. CRKp isolates were collected as part of the prospective, Consortium on Resistance against Carbapenems in Klebsiella and other Enterobacterales 2 (CRACKLE-2) study. Hybrid short-read and long-read genome assemblies were generated from 119 CRKp isolates (95 originated from Houston hospitals). A comprehensive characterization of phylogenies, gene transfer, and plasmid content with pan-genome analysis was performed on all CRKp isolates. Plasmid mating experiments were performed with CG307 and CG258 isolates of interest. Dissection of the accessory genomes suggested independent evolution and limited horizontal gene transfer between CG307 and CG258 lineages. CG307 contained a diverse repertoire of mobile genetic elements, which were shared with other non-CG258 K. pneumoniae isolates. Three unique clades of Houston CG307 isolates clustered distinctly from other global CG307 isolates, indicating potential selective adaptation of particular CG307 lineages to their respective geographical niches. CG307 strains were often isolated from the urine of hospitalized patients, likely serving as important reservoirs for genes encoding carbapenemases and extendedspectrum b-lactamases. Our findings suggest parallel cocirculation of high-risk lineages with potentially divergent evolution.
KW - CG258
KW - CG307
KW - carbapenem-resistant Klebsiella pneumoniae
KW - divergent evolution
KW - genomic surveillance
KW - mobile genetic elements
UR - http://www.scopus.com/inward/record.url?scp=85129064402&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129064402&partnerID=8YFLogxK
U2 - 10.1128/mbio.00497-22
DO - 10.1128/mbio.00497-22
M3 - Article
C2 - 35357213
AN - SCOPUS:85129064402
SN - 2161-2129
VL - 13
JO - mBio
JF - mBio
IS - 2
ER -